February 25, 2026 · Form 4 insider transaction
Rubin Jonathan sold 1,250 shares of Supernus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 1 day after the transaction.
Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.; These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024.